ribociclib
novartis
['kisqali', 'breast']
no clear standard of care for patients with abc without a pik3ca mutation after treatment with a cdk4/6i #asco22 #breastcancer #kisqali #maintain 
Associate Professor, Florence University, Italy. Clinical Oncologist with focus on breast, radiation, research. Opinions are my own. RT not endorsement.